News from debiopharm group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

07 Jun, 2016, 16:15 BST Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1143 in Ovarian Cancer

Debiopharm today announced the start of a phase II clinical trial for Debio 1143 in combination with standard of care Carboplatin and Paclitaxel in...


02 Jun, 2016, 08:00 BST FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer

Debiopharm International SA (Debiopharm), a Swiss-based company, part of Debiopharm Group™, today announced that the FDA Office of Orphan Products...


15 Apr, 2016, 08:00 BST Debiopharm International SA Announces Presentation at AACR of Non-clinical Data Relating to its Targeted Investigational Compound Debio 1347/CH5183284, a Selective FGFR 1,2,3 Inhibitor

Debiopharm International SA (Debiopharm), a Swiss-based company, part of Debiopharm Group™, today announces that non-clinical data on the...


08 Apr, 2016, 08:00 BST Debiopharm International SA to Present the Latest Findings on Debio 1450 at ECCMID

Debiopharm will be present at ECCMID in Amsterdam to share new data supporting the clinical development of its first in class...


04 Mar, 2016, 08:00 GMT Debiopharm International SA Has Won Its Patent Infringement Suit for Elplat® Against Nippon Kayaku Co., Ltd.

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company today announces that the Tokyo...


13 Jan, 2016, 15:00 GMT Debiopharm International SA and EORTC Announce a Collaboration to Investigate Triptorelin for Treatment of Salivary Gland Cancers

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced a collaboration...


11 Jan, 2016, 14:30 GMT Debiopharm International SA and Arbor Pharmaceuticals, LLC Announce Their US Commercialization Partnership for Triptorelin in Central Precocious Puberty

Arbor Pharmaceuticals to commercialize triptorelin in sustained-release formulation for the orphan indication central precocious puberty Debiopharm...


08 Dec, 2015, 08:00 GMT EMA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced that the...


07 Dec, 2015, 08:00 GMT United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines

Pamorelin® one-, three- and six-month dosing option now available to patients in the Philippines United Laboratories Inc. (Unilab) and Debiopharm...


24 Nov, 2015, 08:00 GMT Debiopharm International SA's Partner Yakult Honsha Co, Ltd. Announces Elplat® Approbation in Gastric Cancer in Japan

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, is proud to congratulate its...


03 Nov, 2015, 08:00 GMT Debiopharm International SA Presents Positive Preliminary Results From Phase 1 Trials in the Development of the IAP Inhibitor Debio 1143 at the 27th EORTC-NCI-AACR Symposium in Boston

Recommended Dose reached and early signs of efficacy seen Debiopharm International SA (Debiopharm) - part of Debiopharm Group™, a Swiss-based global...


09 Oct, 2015, 08:00 BST The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2015 JCA-Mauvernay Award

The 'JCA-Mauvernay Award 2015' is awarded to Doctors Yutaka Kondo and Junko Takita Debiopharm Group™, a Swiss-based global biopharmaceutical company, ...


08 Sep, 2015, 08:00 BST Debiopharm International SA and Solid Biosciences, LLC, Announce a Collaboration to Explore the Use of Alisporivir (Debio 025) in Muscular Dystrophy

Debiopharm to start pre-clinical animal studies in Duchenne Muscular Dystrophy (DMD) with Solid Biosciences, a DMD-focused biotech company....


16 Jun, 2015, 13:00 BST Debiopharm International SA Acquires FibroTrap Sample Processing Technology from Spinomix

Applicable to a wide variety of sample types to isolate bacteria, viruses, tumor cells, etc. FibroTrap improves sensitivity and shortens time taken...


19 May, 2015, 08:00 BST Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)

Triptorelin 6-month formulation phase III trial demonstrates good efficacy in terms of pituitary and gonadal suppression and in arresting or...


23 Apr, 2015, 07:30 BST Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections

One year after the initiation of Phase I, Debiopharm announced the start of clinical phase II for Debio 1450 in ABSSSI and presentation of new data...


16 Apr, 2015, 13:00 BST Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference

Debiopharm presents preclinical results for 2 anti-cancer targeted therapies Debio 1143 and Debio 1347 Debiopharm International SA (Debiopharm), part ...


12 Jan, 2015, 07:30 GMT Debiopharm Group™ Regains Full Rights to Alisporivir Program

- Novartis returns Alisporivir (DEB025) to Debiopharm Group™ including all rights for HCV and other indications - Debiopharm Group™ (Debiopharm), a...


08 Jan, 2015, 08:00 GMT FDA Grants Fast Track Designation to Debiopharm Group's Antibiotic Debio 1450

- Debio 1450, oral/IV FabI inhibitor active against all Staphylococcus species has received Fast Track designation for ABSSSI (acute bacterial skin...


06 Mar, 2014, 08:00 GMT Debiopharm Group™ to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of...